Evidence map›Paper›PMID 39936065›Full record

ArticleRomanian journal of ophthalmology

Diabetic Retinopathy Screening Adherence.

Pasha Anvari, Reza Mirshahi, Faezeh Hashemi Nezhad, Alireza Helal Birjandi, Kimia Daneshvar, Ramin Fakhar, Atefeh Ghomashi, Khalil Ghasemi Falavarjani

Abstract readMulticenter Study
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pasha AnvariEye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran; University of Medical Sciences, Tehran, Iran.
Reza MirshahiEye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran; University of Medical Sciences, Tehran, Iran.
Faezeh Hashemi NezhadDepartment of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Alireza Helal BirjandiDepartment of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Kimia DaneshvarSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ramin FakharDepartment of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Atefeh GhomashiDepartment of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Khalil Ghasemi FalavarjaniEye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran; University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the adherence rate of diabetic subjects to the retinopathy screening program and to identify the characteristics associated with non-compliance to regular screening. Methods: A cross-sectional study involving 240 patients with diabetes who attended outpatient non-ophthalmology clinics at four tertiary university hospitals between March 2020 and March 2021 was conducted. A validated questionnaire collected data that included socio-demographic variables, characteristics of diabetes, diabetes-related complications and comorbidities, knowledge and attitudes toward DR and its screening, and barriers to DR screening. Univariate and multivariate logistic regression was employed to identify the factors associated with adherence to the annual diabetic eye examination. Adherence was defined as a history of the dilated ophthalmic exam in the past year and subsequent follow-ups recommended by the ophthalmologist. Results: The participants had an average age of 59 ± 14.2 years, and 53% were females. The average duration of diabetes was 108 ± 89.62 months. Based on the last ophthalmic examination, 50.8% of patients were non-adherent to the suggested DR screening guidelines. A history of smoking (p-value=0.013, 95%CI for OR: 1.21-5.10), lower education levels (p-value=0.045, 95%CI for OR: 1.02-3.82), and not clarifying the necessity of ophthalmic examination by primary physicians (p-value < 0.001, 95%CI for OR: 2.19-12.35) were significantly associated with non-adherence. Among non-adherent subjects, 38% reported fear of the COVID-19 pandemic, 21.3% cited the lack of information regarding DR screening, 10.7% cited lack of access to the ophthalmologist, 5.7% cited financial problems, and 10.7% noted a lack of support from family and friends as the main reason for non-attendance to the annual eye care. Discussions: This study revealed a non-compliance rate with DR screening guidelines that surpasses pre-pandemic figures. Although younger participants demonstrated a higher likelihood of recent eye care, this correlation lost significance in multivariate analysis, potentially reflecting education and technology utilization disparities. Despite uniform insurance coverage, socioeconomic factors, such as transportation challenges, may impede adherence. Furthermore, individuals informed by healthcare providers about the necessity of eye exams exhibited greater compliance; however, many newly diagnosed patients remained unaware of the risks associated with DR. The COVID-19 pandemic emerged as a prominent barrier, with numerous patients citing it as a reason for their non-compliance due to disruptions in clinical care. Conclusions: Half of the diabetic subjects attending tertiary hospitals for non-ophthalmic complaints were non-adherent to recommended retinopathy screening. Lower education, smoking, and unawareness of the necessity of annual eye care had the strongest association with non-compliance. Fear of contracting COVID-19 was the most prevalent barrier to the eye examination. These findings underscore the necessity for targeted patient education initiatives, particularly among those with lower education levels and smokers.

Indexed as

Diabetic RetinopathyMass ScreeningPatient ComplianceAdultAgedCOVID-19Cross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSurveys and QuestionnairesAAO = The American Academy of OphthalmologyADA = the American Diabetes Associationadherenceanti-VEGF = anti-vascular endothelial growth factor therapyBCVA = best-corrected visual acuityCOVIDCOVID = Coronavirus diseasediabetic retinopathyDM = diabetes mellitusDR = Diabetic retinopathyscreening guidelines

Identifiers

PMID39936065
PMCPMC11809822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.